128 related articles for article (PubMed ID: 15322249)
41. The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity.
Schneider F; Neugebauer J; Griese J; Liefold N; Kutz H; Briseño C; Kieser A
PLoS Biol; 2008 Jan; 6(1):e8. PubMed ID: 18198944
[TBL] [Abstract][Full Text] [Related]
42. Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression.
Potapova O; Anisimov SV; Gorospe M; Dougherty RH; Gaarde WA; Boheler KR; Holbrook NJ
Cancer Res; 2002 Jun; 62(11):3257-63. PubMed ID: 12036942
[TBL] [Abstract][Full Text] [Related]
43. Identification of p55 tumor necrosis factor receptor-associated proteins that couple to signaling pathways not initiated by the death domain.
Adam D; Adam-Klages S; Krönke M
J Inflamm; 1995-1996; 47(1-2):61-6. PubMed ID: 8913930
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells.
Yauch RL; Kadel EE; Nicholas C; Tetangco S; Clary DO
J Biomol Screen; 2004 Dec; 9(8):704-11. PubMed ID: 15634797
[TBL] [Abstract][Full Text] [Related]
45. Activation of Jun N-terminal kinase/stress-activated protein kinase pathway by tumor necrosis factor alpha leads to intercellular adhesion molecule-1 expression.
De Cesaris P; Starace D; Starace G; Filippini A; Stefanini M; Ziparo E
J Biol Chem; 1999 Oct; 274(41):28978-82. PubMed ID: 10506145
[TBL] [Abstract][Full Text] [Related]
46. Apoptosis-inducing agents cause rapid shedding of tumor necrosis factor receptor 1 (TNFR1). A nonpharmacological explanation for inhibition of TNF-mediated activation.
Madge LA; Sierra-Honigmann MR; Pober JS
J Biol Chem; 1999 May; 274(19):13643-9. PubMed ID: 10224136
[TBL] [Abstract][Full Text] [Related]
47. Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons.
Del Villar K; Miller CA
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4210-5. PubMed ID: 15007167
[TBL] [Abstract][Full Text] [Related]
48. Systematic mutational analysis of the death domain of the tumor necrosis factor receptor 1-associated protein TRADD.
Park A; Baichwal VR
J Biol Chem; 1996 Apr; 271(16):9858-62. PubMed ID: 8621670
[TBL] [Abstract][Full Text] [Related]
49. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
Bennett CF; Chiang MY; Chan H; Shoemaker JE; Mirabelli CK
Mol Pharmacol; 1992 Jun; 41(6):1023-33. PubMed ID: 1352033
[TBL] [Abstract][Full Text] [Related]
50. TRAF1: lord without a RING.
Zapata JM; Reed JC
Sci STKE; 2002 May; 2002(133):pe27. PubMed ID: 12023442
[TBL] [Abstract][Full Text] [Related]
51. Hydroid TNF-receptor-associated factor (TRAF) and its splice variant: a role in development.
Mali B; Frank U
Mol Immunol; 2004 Jun; 41(4):377-84. PubMed ID: 15163534
[TBL] [Abstract][Full Text] [Related]
52. Phase I trial of ISIS 104838, a 2'-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-alpha.
Sewell KL; Geary RS; Baker BF; Glover JM; Mant TG; Yu RZ; Tami JA; Dorr FA
J Pharmacol Exp Ther; 2002 Dec; 303(3):1334-43. PubMed ID: 12438559
[TBL] [Abstract][Full Text] [Related]
53. Tumor necrosis factor receptor superfamily.
Naismith JH; Sprang SR
J Inflamm; 1995-1996; 47(1-2):1-7. PubMed ID: 8913924
[TBL] [Abstract][Full Text] [Related]
54. [The study of relationship between c-erbB2 expression and cytoimmunology in ovarian carcinoma and its antisense regulation].
Jin Z; Zhang X; Feng Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Apr; 30(4):222-4. PubMed ID: 7664609
[TBL] [Abstract][Full Text] [Related]
55. Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha.
Schmid EF; Binder K; Grell M; Scheurich P; Pfizenmaier K
Blood; 1995 Sep; 86(5):1836-41. PubMed ID: 7544644
[TBL] [Abstract][Full Text] [Related]
56. Activation of tissue plasminogen activator gene transcription by Neovastat, a multifunctional antiangiogenic agent.
Gingras D; Nyalendo C; Di Tomasso G; Annabi B; Béliveau R
Biochem Biophys Res Commun; 2004 Jul; 320(1):205-12. PubMed ID: 15207722
[TBL] [Abstract][Full Text] [Related]
57. Roles of the adaptor protein tumor necrosis factor receptor type 1-associated death domain protein (TRADD) in human diseases.
Chen Y; Gu Y; Xiong X; Zheng Y; Liu X; Wang W; Meng G
Biomed Pharmacother; 2022 Sep; 153():113467. PubMed ID: 36076575
[TBL] [Abstract][Full Text] [Related]
58. NPM-RAR binding to TRADD selectively inhibits caspase activation, while allowing activation of NFκB and JNK.
Chattopadhyay A; Abecassis I; Redner RL
Leuk Lymphoma; 2015; 56(12):3401-3406. PubMed ID: 25791120
[TBL] [Abstract][Full Text] [Related]
59. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors.
Hohmann HP; Brockhaus M; Baeuerle PA; Remy R; Kolbeck R; van Loon AP
J Biol Chem; 1990 Dec; 265(36):22409-17. PubMed ID: 2176217
[TBL] [Abstract][Full Text] [Related]
60. [Induction of gene expression by TNF-alpha and steroid stimulations in cultured human umbilical vascular endothelial cells].
Yamamoto Y
Hokkaido Igaku Zasshi; 2003 Nov; 78(6):541-8. PubMed ID: 14672041
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
